Inhibitors of tyrosine phosphatases block angiotensin II inhibition of Na+ pump

European Journal of Pharmacology

Volumn 406, Issue 1, 2000, Pages 49-52

  Yingst, Douglas R ^a   Davis, Joanne ^b   Schiebinger, Rick ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Aldosterone; Ca2+; Na(+) K(+) exchanging ATPase; Na+; Ouabain

Indexed keywords

1,6 HEXAMETHYLENEDICARBAMIC ACID BIS(CYCLOHEXANONE OXIME) ESTER; 4 BROMOTETRAMISOLE OXALIC ACID; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; ARSENOSOBENZENE; CALPHOSTIN C; CYANOGINOSIN; LIPOPROTEIN LIPASE; MEPACRINE; OKADAIC ACID; OUABAIN; PHOSPHATASE; PHOSPHOLIPASE A2; PROTEIN TYROSINE KINASE; STAUROSPORINE; TRIFLUOROMETHYL KETONE; TYRPHOSTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; FEMALE; HUMAN CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; ZONA GLOMERULOSA;

ANGIOTENSIN II; ANIMALS; ARACHIDONIC ACID; ARSENICALS; ENZYME INHIBITORS; FEMALE; NA(+)-K(+)-EXCHANGING ATPASE; NAPHTHALENES; PHOSPHOLIPASES A; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; STAUROSPORINE; TETRAMISOLE; TYROSINE;

EID: 0034613204     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00664-6     Document Type: Article

References (22)

1. +-ATPase. Clin. Exp. Hypertens. 20:1998;465-480.
2. Bialojan C., Takai A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem. J. 256:1988;283-290.
3. Bodart V., Ong H., DeLean A. A role for protein tyrosine kinase in the steroidogenic pathway of angiotensin II in bovine zona glomerulosa cells. J. Steroid Biochem. Mol. Biol. 54:1995;55-62.
4. Burnier M., Brunner H.R. Angioensin II receptor antagonists. Lancet. 355:2000;637-645.
5. Craven T.G., Kem D.C., Schiebinger R.J. Atrial natriuretic peptides: the role of phenylalanine on biological activity. Endocrinology. 122:1988;826-830.
6. +-ATPase activity. FEBS Lett. 456:1999;45-48.
7. +-ATPase activity in kidney proximal tubule cells depends on phosphorylation of the alpha-subunit at Tyr-10. Mol. Biol. Cell. 10:1999;2847-2859.
8. Gazit A., Yaish P., Gilon C., Levitzki A. Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32:1989;2344-2352.
9. +pump in rat adrenal glomerulosa cells: possible contribution to stimulation of aldosterone production. Endocrinology. 130:1992;1637-1644.
10. Hofmann S.L., Prescott S.M., Majerus P.W. The effects of mepacrine and p-bromophenacyl bromide on arachidonic acid release in human platelets. Arch. Biochem. Biophys. 215:1982;237-244.
11. Hunyady L., Merelli F., Baukal A.J., Balla T., Catt K.J. Agonist-induced endocytosis and signal generation in adrenal glomerulosa cells. A potential mechanism for receptor-operated calcium entry. J. Biol. Chem. 266:1991;2783-2788.
12. Kapas S., Purbrick A., Hinson J.P. Role of tyrosine kinase and protein kinase C in the steroidogenic actions of angiotensin II, alpha-melanocyte-stimulating hormone and corticotropin in the rat adrenal cortex. Biochem. J. 305:1995;433-438.
13. Kovach J.S., Svingen P.A., Schaid D.J. Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase. J. Nat. Cancer Inst. 84:1992;515-519.
14. Liao K., Hoffman R.D., Lane M.D. Phosphotyrosyl turnover in insulin signaling. Characterization of two membrane-bound pp15 protein tyrosine phosphatases from 3T3-L1 adipocytes. J. Biol. Chem. 266:1991;6544-6553.
15. MacKintosh C., Beattie K.A., Klumpp S., Cohen P., Codd G.A. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants. FEBS Lett. 264:1990;187-192.
16. Mizuno K., Noda K., Ueda Y., Hanaki H., Saido T.C., Ikuta T., Kuroki T., Tamaoki T., Hirai S., Osada S. UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily. FEBS Lett. 359:1995;259-261.
17. Morioka M., Fukunaga K., Kawano T., Hasegawa S., Korematsu K., Kai K., Hamada J., Miyamoto E., Ushio Y. Serine/threonine phosphatase activity of calcineurin is inhibited by sodium orthovanadate and dithiothreitol reverses the inhibitory effect. Biochem. Biophys. Res. Commun. 253:1998;342-345.
18. Moriyama T., Urade R., Kito M. Purification and characterization of diacylglycerol lipase from human platelets. J. Biochem. 125:1999;1077-1085.
19. Scher B.M., Wei X.J., Waxman S., Scher W. Dephosphorylation of Vav is associated with the induction of mouse erythroleukemia cell differentiation: effects of orthovanadate and levamisole. Int. J. Oncol. 12:1998;1307-1313.
20. Street I.P., Lin H.K., Laliberte F., Ghomashchi F., Wang Z., Perrier H., Tremblay N.M., Huang Z., Weech P.K., Gelb M.H. Slow- and tight-binding inhibitors of the 83-kDa human phospholipase Ap2. Biochemistry. 32:1993;5935-5940.
21. Tian Y., Smith R.D., Balla T., Catt K.J. Angiotensin II activates mitogen-activated protein kinase via protein kinase C and Ras/Raf-1 kinase in bovine adrenal glomerulosa cells. Endocrinology. 139:1998;1801-1809.
22. Yingst D.R., Davis J., Krenz S., Schiebinger R.J. Insights into the mechanism by which inhibition of NaK-ATPase stimulates aldosterone secretion. Metabolism. 48:1999;1167-1171.